Is Wall Street Bullish or Bearish on Danaher Stock?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 16 2025
0mins
Source: NASDAQ.COM
Company Performance: Danaher Corporation (DHR) has seen a significant decline of 27.5% in its stock over the past year, underperforming compared to the S&P 500 Index and the Robo Global Healthcare Technology and Innovation ETF, despite reporting better-than-expected Q1 results with an adjusted EPS of $1.88.
Analyst Ratings: The consensus among analysts is a "Strong Buy" for DHR, with a mean price target of $242.76 indicating a potential upside of 27.1%, while Scotiabank maintains a "Hold" rating with a price target of $265, suggesting a possible upside of 38.8%.
Analyst Views on HTEC
Wall Street analysts forecast HTEC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HTEC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 38.060
Low
Averages
High
Current: 38.060
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
